JP2955886B2 - Pyrrolidine derivative and method for producing the same - Google Patents
Pyrrolidine derivative and method for producing the sameInfo
- Publication number
- JP2955886B2 JP2955886B2 JP2411400A JP41140090A JP2955886B2 JP 2955886 B2 JP2955886 B2 JP 2955886B2 JP 2411400 A JP2411400 A JP 2411400A JP 41140090 A JP41140090 A JP 41140090A JP 2955886 B2 JP2955886 B2 JP 2955886B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- lower alkyl
- alkyl group
- substituted
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は抗菌活性を有するペネム
化合物およびカルバペネム化合物の中間体およびその製
造方法に関する。さらに詳しく言えば、特開昭60-19787
号公報、特開昭60-58987号公報および特開昭60-104088
号公報において優れた抗菌活性を有することが知られて
いるペネム化合物およびカルバペネム化合物の2位側鎖
部分を構築する際に重要な中間体となる、一般式(1)BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an intermediate of a penem compound and a carbapenem compound having antibacterial activity and a method for producing the same. More specifically, JP-A-60-19787
JP, JP-A-60-58987 and JP-A-60-104088
General formula (1), which is an important intermediate when constructing the side chain portion of the 2-position of penem compounds and carbapenem compounds known to have excellent antibacterial activity in the publication
【化4】 [式中、Phはフェニル基を示し、Rはアミノ基の保護
基を示し、R1 は水素原子、低級アルキル基、低級アル
ケニル基、アラルキル基もしくは置換低級アルキル基を
示し、R2 は低級アルキル基、低級アルケニル基、アラ
ルキル基もしくは置換低級アルキル基を示すか、または
R1 およびR2 は互いに結合し一緒になってアルキレン
鎖、または酸素原子、硫黄原子もしくは低級アルキル置
換の窒素原子を介するアルキレン鎖を表わして隣接する
窒素原子とともに4〜7員環の環状アミノ基を示す。]
で表わされる2−アミノカルボニル−ピロリジン誘導体
およびその製造方法に関するものである。Embedded image Wherein Ph represents a phenyl group, R represents an amino-protecting group, R 1 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, an aralkyl group or a substituted lower alkyl group, and R 2 represents a lower alkyl group. Or a lower alkenyl group, an aralkyl group or a substituted lower alkyl group, or R 1 and R 2 are bonded to each other to form an alkylene chain, or an alkylene chain via an oxygen atom, a sulfur atom, or a nitrogen atom substituted with a lower alkyl group. The chain represents a 4- to 7-membered cyclic amino group together with an adjacent nitrogen atom. ]
And a method for producing the same.
【0002】[0002]
【従来の技術】上記刊行物に記載されているペネム化合
物およびカルバペネム化合物を製造するための中間体と
しては、一般式(3)2. Description of the Related Art As an intermediate for producing a penem compound and a carbapenem compound described in the above publication, a compound represented by the general formula (3):
【化5】 [式中、R、R1 およびR2 は前記と同じ意味を有
す。]で示される化合物が知られている。Embedded image Wherein R, R 1 and R 2 have the same meaning as described above. ] Are known.
【0003】[0003]
【発明が解決しようとする課題】本発明者らは、一般式
(1)で示される本発明化合物が一般式(3)で示され
る化合物と比べ、結晶性により優れていることから、上
記ペネム化合物およびカルバペネム化合物を大量製造す
る上で非常に有用な中間体となることを見出し、本発明
を完成したものである。DISCLOSURE OF THE INVENTION The present inventors have found that the compound of the present invention represented by the general formula (1) is more excellent in crystallinity than the compound represented by the general formula (3). The present invention has been found to be a very useful intermediate for mass production of compounds and carbapenem compounds, and has completed the present invention.
【0004】[0004]
【課題を解決するための手段】以下、本発明化合物およ
びその製造方法について詳述する。一般式(1)にて示
される本発明化合物において、Rで表わされるアミノ基
の保護基としては、例えばtert−ブチルオキシカルボニ
ルのような低級アルコキシカルボニル基、例えば2−ヨ
ウ化エチルオキシカルボニル、2,2,2−トリクロロ
エチルオキシカルボニルのようなハロゲノ低級アルコキ
シカルボニル基、例えばアリルオキシカルボニル、2−
クロロアリルオキシカルボニルのようなハロゲン原子に
よって任意に置換されている低級アルケニルオキシカル
ボニル基、例えばベンジルオキシカルボニル、p−メト
キシベンジルオキシカルボニル、o−ニトロベンジルオ
キシカルボニル、p−ニトロベンジルオキシカルボニル
のようなアラルキルオキシカルボニル基を挙げることが
できる。BEST MODE FOR CARRYING OUT THE INVENTION The compound of the present invention and a method for producing the same will be described in detail below. In the compound of the present invention represented by the general formula (1), examples of the protecting group for the amino group represented by R include a lower alkoxycarbonyl group such as tert-butyloxycarbonyl, for example, 2-ethyliodoxycarbonyl, Halogeno lower alkoxycarbonyl groups such as 2,2,2-trichloroethyloxycarbonyl, for example, allyloxycarbonyl, 2-
Lower alkenyloxycarbonyl groups optionally substituted by halogen atoms such as chloroallyloxycarbonyl, such as benzyloxycarbonyl, p-methoxybenzyloxycarbonyl, o-nitrobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl An aralkyloxycarbonyl group can be mentioned.
【0005】R1 およびR2 が表わす低級アルキル基と
しては、例えばメチル、エチル、n−プロピル、イソプ
ロピル、n−ブチル等の炭素数1〜4個のアルキル基を
挙げることができ、低級アルケニル基としては、例えば
プロペニル、ブテニル等の炭素数2〜4個のアルケニル
基を挙げることができ、アラルキル基としては、例えば
ベンジル、置換ベンジル、フェネチル等のフェニル基も
しくは置換フェニル基で置換された炭素数1〜3個のア
ルキル基を挙げることができ、置換低級アルキル基とし
ては、例えば水酸基、アミノ基、低級アルキルアミノ
基、ジ低級アルキルアミノ基、カルバモイル基、カルボ
キシル基、低級アルコキシカルボニル基、アラルキルオ
キシカルボニル基等で置換された炭素数1〜4個のアル
キル基を挙げることができる。The lower alkyl groups represented by R 1 and R 2 include, for example, alkyl groups having 1 to 4 carbon atoms such as methyl, ethyl, n-propyl, isopropyl and n-butyl. Examples thereof include alkenyl groups having 2 to 4 carbon atoms such as propenyl and butenyl. Examples of the aralkyl group include phenyl groups such as benzyl, substituted benzyl and phenethyl or carbon atoms substituted with a substituted phenyl group. Examples of the substituted lower alkyl group include a hydroxyl group, an amino group, a lower alkylamino group, a di-lower alkylamino group, a carbamoyl group, a carboxyl group, a lower alkoxycarbonyl group, and an aralkyloxy group. To mention an alkyl group having 1 to 4 carbon atoms substituted by a carbonyl group or the like. it can.
【0006】またR1 およびR2 は互いに結合し一緒に
なって表わすアルキレン鎖、または酸素原子、硫黄原子
もしくは低級アルキル置換の窒素原子を介するアルキレ
ン鎖を表わして隣接する窒素原子とともに形成する4〜
7員環の環状アミノ基としては、例えばアゼチジノ基、
ピペリジノ基、ピロリジノ基、モルホリノ基、チオモル
ホリノ基、N−メチルモルホリノ基等を挙げることがで
きる。R 1 and R 2 represent an alkylene chain bonded and bonded together or an alkylene chain via an oxygen atom, a sulfur atom or a lower alkyl-substituted nitrogen atom, and formed together with an adjacent nitrogen atom.
Examples of the 7-membered cyclic amino group include an azetidino group,
Examples thereof include a piperidino group, a pyrrolidino group, a morpholino group, a thiomorpholino group, and an N-methylmorpholino group.
【0007】一般式(1)で示される本発明化合物には
2位および4位の不斉炭素に基づく立体異性体が存在
し、これら異性体が便宜上すべて単一の式で示されてい
るが、もちろん本発明はこれら異性体をすべて含むもの
である。しかしながら、ペネム化合物およびカルバペネ
ム化合物の中間体として好適なものとしては、[2S,
4S]配位および[2R,4R]配位の化合物を挙げる
ことができる。The compound of the present invention represented by the general formula (1) has stereoisomers based on the asymmetric carbon at the 2-position and 4-position, and these isomers are all represented by a single formula for convenience. Of course, the present invention includes all these isomers. However, suitable intermediates for penem compounds and carbapenem compounds include [2S,
4S] and [2R, 4R] coordination compounds.
【0008】一般式(1)General formula (1)
【化6】 [式中、Ph、R、R1 およびR2 は前記と同じ意味を
有す。]で表わされる本発明化合物は、一般式(2)Embedded image [Wherein, Ph, R, R 1 and R 2 have the same meaning as described above. The compound of the present invention represented by the general formula (2)
【化7】 [式中、Xは水酸基の活性エステル基を示し、R、R1
およびR2 は前記と同じ意味を有す。]で表わされる化
合物をチオ安息香酸のアルカリ金属塩と不活性溶媒中で
加熱処理することにより得ることができる。Embedded image [Wherein, X represents an active ester group of a hydroxyl group, and R and R 1
And R 2 have the same meaning as described above. Can be obtained by subjecting an alkali metal thiobenzoate to heat treatment in an inert solvent.
【0009】不活性溶媒としては、ベンゼン、トルエン
などの芳香族炭化水素類、クロルベンゼン、o−ジクロ
ルベンゼンなどの芳香族ハロゲン化炭化水素類、アセト
ニトリル、ジメチルホルムアミド、ジメチルアセトアミ
ド、スルホランなどの非プロトン性極性溶媒、およびこ
れらの有機溶媒の混合溶媒を挙げることができるが、好
ましくはトルエンとジメチルホルムアミドあるいはクロ
ルベンゼンとジメチルホルムアミドの混合溶媒である。Examples of the inert solvent include aromatic hydrocarbons such as benzene and toluene, aromatic halogenated hydrocarbons such as chlorobenzene and o-dichlorobenzene, and non-solvents such as acetonitrile, dimethylformamide, dimethylacetamide and sulfolane. Protic polar solvents and mixed solvents of these organic solvents can be mentioned, and preferred are toluene and dimethylformamide or a mixed solvent of chlorobenzene and dimethylformamide.
【0010】チオ安息香酸のアルカリ金属塩として使用
されるアルカリ金属塩としては、リチウム、ナトリウ
ム、カリウムを挙げることができるが、好ましくはカリ
ウムである。The alkali metal salt used as the alkali metal salt of thiobenzoic acid includes lithium, sodium and potassium, and preferably potassium.
【0011】反応温度としては50℃〜150℃の範囲
が可能であるが、副反応を抑制するためには60℃〜8
0℃の範囲で実施することが好ましい。反応終了後は通
常の有機化学的手法によって成績体を取り出すことがで
きるが、本製造方法は溶媒を留去した後、結晶化精製に
て成績体を得ることができることに特徴がある。The reaction temperature can be in the range of 50 ° C. to 150 ° C.
It is preferable to carry out in the range of 0 ° C. After completion of the reaction, the product can be obtained by a usual organic chemical technique. However, the present production method is characterized in that the product can be obtained by crystallization purification after distilling off the solvent.
【0012】以上の方法で得られた一般式(1)にて示
される本発明化合物は下記の反応式に示すようにアルカ
リ金属の塩基を用いる加水分解反応または加溶媒分解反
応により、メルカプタン誘導体に変換され、その後公知
の方法により優れた抗菌活性を有するペネム化合物およ
びカルバペネム化合物に誘導される。The compound of the present invention represented by the general formula (1) obtained by the above method is converted into a mercaptan derivative by a hydrolysis reaction or a solvolysis reaction using an alkali metal base as shown in the following reaction formula. It is then converted into penem compounds and carbapenem compounds having excellent antibacterial activity by known methods.
【化8】 [式中、Ph、R、R1 およびR2 は前記と同じ意味を
有す。]Embedded image [Wherein, Ph, R, R 1 and R 2 have the same meaning as described above. ]
【0013】なお、本発明の方法において使用される一
般式(2)で表わされる原料化合物は、4−ヒドロキシ
プロリンより Journal of Antibiotics 43(5),5
19〜532(1990)に記載の方法に準じて製造するこ
とができる。The starting compound represented by the general formula (2) used in the method of the present invention is obtained from 4-hydroxyproline in the Journal of Antibiotics 43 (5), 5
19 to 532 (1990).
【0014】[0014]
【実施例】次に、実施例および参考例を挙げて本発明を
さらに具体的に説明するが、本発明はもちろんこれらに
よって限定されるものではない。なお、以下の実施例お
よび参考例で用いた略号の意味は次のとおりである。EXAMPLES Next, the present invention will be described more specifically with reference to examples and reference examples, but the present invention is of course not limited thereto. The meanings of the abbreviations used in the following Examples and Reference Examples are as follows.
【0015】 Ms : メタンスルホニル基、 Me : メチル基、 Ph : フェニル基。Ms: methanesulfonyl group, Me: methyl group, Ph: phenyl group.
【0016】 実施例1−(1)Embodiment 1- (1)
【化9】 Embedded image
【0017】(2S,4R)−N,N−ジメチル−1−
アリルオキシカルボニル−4−メタンスルホニルオキシ
−2−ピロリジンカルボキシアミド(25.3g)を含む油
状の残渣(30g)にトルエン(145ml)、ジメチル
ホルムアミド(145ml)、さらにチオ安息香酸カリウ
ム(14.2g)を加え、70℃で4.5 時間撹拌した。反応
液を30℃以下まで冷却し、トルエン(700ml)、1
0%食塩水(700ml)を加えて抽出、分液の後、水層
をトルエン(200ml)で再抽出し、トルエン層を先の
有機層と合わせ、10%食塩水(350ml)で5回洗浄
した。硫酸マグネシウムで乾燥後、溶媒留去した。得ら
れた油状の残渣にn−ヘキサン(51ml)と酢酸エチル
(8.5 ml)を注入して60℃まで加熱し、30分間撹拌
した。30℃まで冷却して種晶5gを添加し、そのまま
1時間撹拌した後、さらに0℃まで冷却してそのまま1
時間撹拌した。析出した結晶を集め、n−ヘキサンと酢
酸エチルの混合溶媒(70:30)で洗浄し、減圧下乾
燥して、(2S,4S)−N,N−ジメチル−1−アリ
ルオキシカルボニル−4−ベンゾイルチオ−2−ピロリ
ジンカルボキシアミド(13.6g)を得た。(2S, 4R) -N, N-dimethyl-1-
To an oily residue (30 g) containing allyloxycarbonyl-4-methanesulfonyloxy-2-pyrrolidinecarboxamide (25.3 g) was added toluene (145 ml), dimethylformamide (145 ml), and potassium thiobenzoate (14.2 g). And stirred at 70 ° C. for 4.5 hours. The reaction solution was cooled to 30 ° C. or lower, and toluene (700 ml), 1
A 0% saline solution (700 ml) was added for extraction and separation. After separation, the aqueous layer was re-extracted with toluene (200 ml), and the toluene layer was combined with the previous organic layer and washed five times with 10% saline (350 ml). did. After drying over magnesium sulfate, the solvent was distilled off. N-Hexane (51 ml) and ethyl acetate (8.5 ml) were poured into the obtained oily residue, heated to 60 ° C, and stirred for 30 minutes. After cooling to 30 ° C., 5 g of seed crystal was added, and the mixture was stirred for 1 hour.
Stirred for hours. The precipitated crystals were collected, washed with a mixed solvent of n-hexane and ethyl acetate (70:30) and dried under reduced pressure to give (2S, 4S) -N, N-dimethyl-1-allyloxycarbonyl-4-. Benzoylthio-2-pyrrolidinecarboxamide (13.6 g) was obtained.
【0018】 融点(mp):99.5〜101.5 ℃; IR(Nujol ):1690, 1665, 1650cm-1。Melting point (mp): 99.5-101.5 ° C .; IR (Nujol): 1690, 1665, 1650 cm −1 .
【0019】上記の方法においてチオ安息香酸カリウム
のかわりにチオ酢酸カリウムを用いて得られる(2S,
4S)−N,N−ジメチル−1−アリルオキシカルボニ
ル−4−アセチルチオ−2−ピロリジンカルボキシアミ
ドの融点(mp)は75〜76℃であった。In the above method, potassium thioacetate is used instead of potassium thiobenzoate (2S,
The melting point (mp) of 4S) -N, N-dimethyl-1-allyloxycarbonyl-4-acetylthio-2-pyrrolidinecarboxamide was 75 to 76 ° C.
【0020】 実施例1−(2) (2S,4R)−N,N−ジメチル−1−アリルオキシ
カルボニル−4−メタンスルホニルオキシ−2−ピロリ
ジンカルボキシアミド(4.14g)を含む油状の残渣にト
ルエン(30ml)、ジメチルホルムアミド(8ml)、さ
らにチオ安息香酸カリウム(2.8 g)を加え、70℃で
5時間撹拌した。反応液に水(20ml)を加えて分液
後、水層をトルエン(30ml)で再抽出し、トルエン層
を先の有機層と合わせ、水(20ml)で2回洗浄した。
硫酸マグネシウムで乾燥後、溶媒留去し、得られた油状
残渣をn−ヘキサンと酢酸エチルの混合溶媒から結晶化
して、(2S,4S)−N,N−ジメチル−1−アリル
オキシカルボニル−4−ベンゾイルチオ−2−ピロリジ
ンカルボキシアミド(2.19g)を得た。Example 1- (2) Toluene was added to an oily residue containing (2S, 4R) -N, N-dimethyl-1-allyloxycarbonyl-4-methanesulfonyloxy-2-pyrrolidinecarboxamide (4.14 g). (30 ml), dimethylformamide (8 ml) and potassium thiobenzoate (2.8 g) were added, and the mixture was stirred at 70 ° C. for 5 hours. After water (20 ml) was added to the reaction solution and the layers were separated, the aqueous layer was re-extracted with toluene (30 ml), and the toluene layer was combined with the previous organic layer and washed twice with water (20 ml).
After drying over magnesium sulfate, the solvent was distilled off, and the obtained oily residue was crystallized from a mixed solvent of n-hexane and ethyl acetate to give (2S, 4S) -N, N-dimethyl-1-allyloxycarbonyl-4 -Benzoylthio-2-pyrrolidinecarboxamide (2.19 g) was obtained.
【0021】 実施例1−(3) (2S,4R)−N,N−ジメチル−1−アリルオキシ
カルボニル−4−メタンスルホニルオキシ−2−ピロリ
ジンカルボキシアミド(4.09g)を含む油状の残渣にト
ルエン(40ml)、さらにチオ安息香酸カリウム(2.45
g)を加え、還流下で3時間撹拌した。反応液にトルエ
ン(40ml)を加え、10%食塩水(30ml)で3回洗
浄した。硫酸マグネシウムで乾燥後、溶媒留去し、得ら
れた油状残渣をn−ヘキサンと酢酸エチルの混合溶媒か
ら結晶化して、(2S,4S)−N,N−ジメチル−1
−アリルオキシカルボニル−4−ベンゾイルチオ−2−
ピロリジンカルボキシアミド(1.77g)を得た。Example 1- (3) Toluene was added to an oily residue containing (2S, 4R) -N, N-dimethyl-1-allyloxycarbonyl-4-methanesulfonyloxy-2-pyrrolidinecarboxamide (4.09 g). (40 ml) and potassium thiobenzoate (2.45)
g) was added and the mixture was stirred under reflux for 3 hours. Toluene (40 ml) was added to the reaction solution, and the mixture was washed three times with 10% saline (30 ml). After drying over magnesium sulfate, the solvent was distilled off, and the obtained oily residue was crystallized from a mixed solvent of n-hexane and ethyl acetate to give (2S, 4S) -N, N-dimethyl-1.
-Allyloxycarbonyl-4-benzoylthio-2-
Pyrrolidine carboxamide (1.77 g) was obtained.
【0022】 参考例1Reference Example 1
【化10】 Embedded image
【0023】チオ安息香酸(30.4g)をメタノール(1
6ml)に溶解し、これに氷冷下水酸化カリウム(11.2
g)のメタノール(40ml)溶液を滴下し、そのまま1
時間撹拌した後、減圧下、メタノールを約40ml留去し
た。濃縮残渣を酢酸エチル(300ml)に溶解し、氷冷
した後、n−ヘキサン(120ml)を滴下し、そのまま
30分撹拌した。析出した結晶を集め、n−ヘキサンと
酢酸エチルの混合溶媒で洗浄し、減圧乾燥してチオ安息
香酸カリウム(23.5g)を得た。Thiobenzoic acid (30.4 g) was added to methanol (1
6 ml) and add potassium hydroxide (11.2
g) in methanol (40 ml) was added dropwise.
After stirring for about 30 hours, about 40 ml of methanol was distilled off under reduced pressure. The concentrated residue was dissolved in ethyl acetate (300 ml), cooled with ice, n-hexane (120 ml) was added dropwise, and the mixture was stirred for 30 minutes. The precipitated crystals were collected, washed with a mixed solvent of n-hexane and ethyl acetate, and dried under reduced pressure to obtain potassium thiobenzoate (23.5 g).
【0024】 参考例2Reference Example 2
【化11】 Embedded image
【0025】トランス−4−ヒドロキシ−L−プロリン
(35.9g)と水酸化ナトリウム(23.9g)を水(330
ml)に溶解し、これにクロル炭酸アリル(36.3g)の塩
化メチレン(250ml)溶液を氷冷下で滴下し、そのま
ま2時間撹拌した。反応液から水層を分離し、これを塩
化メチレン(100ml)で2回洗浄した後、30℃以下
で濃硫酸(25g)を滴下して酸性とした。次に、食塩
(120g)を加え酢酸エチル(220ml)で2回抽出
した。酢酸エチル抽出液を硫酸マグネシウムで乾燥後、
溶媒留去し、トランス−1−アリルオキシカルボニル−
4−ヒドロキシ−L−プロリンの粗結晶(62g)を得
た。粗結晶はトルエンでリパルプ精製して、融点(m
p)93〜94℃のトランス−1−アリルオキシカルボ
ニル−4−ヒドロキシ−L−プロリン(56.1g)を得
た。Trans-4-hydroxy-L-proline (35.9 g) and sodium hydroxide (23.9 g) were added to water (330
ml), and a solution of allyl chlorocarbonate (36.3 g) in methylene chloride (250 ml) was added dropwise under ice-cooling, followed by stirring for 2 hours. The aqueous layer was separated from the reaction solution, washed twice with methylene chloride (100 ml), and made acidic by dropwise addition of concentrated sulfuric acid (25 g) at 30 ° C. or lower. Next, sodium chloride (120 g) was added, and the mixture was extracted twice with ethyl acetate (220 ml). After drying the ethyl acetate extract with magnesium sulfate,
The solvent was distilled off and trans-1-allyloxycarbonyl-
Crude crystals of 4-hydroxy-L-proline (62 g) were obtained. The crude crystals were repulped and refined with toluene to give a melting point (m
p) Trans-1-allyloxycarbonyl-4-hydroxy-L-proline (56.1 g) at 93-94 ° C. was obtained.
【0026】 IR(Nujol ):3300, 1740, 1675, 1645cm-1。IR (Nujol): 3300, 1740, 1675, 1645 cm −1 .
【0027】 参考例3Reference Example 3
【化12】 Embedded image
【0028】トランス−1−アリルオキシカルボニル−
4−ヒドロキシ−L−プロリン(28.6g)を含む粗結晶
(31g)を塩化メチレン(465ml)に溶解し、これ
にトリエチルアミン(6.6 g)を加えた後、還流下に塩
化メチレン(95ml)を加え、同量を留出させて共沸脱
水を行なった。同様の操作でさらに3回共沸脱水を行な
った後、−10℃まで冷却し、メタンスルホニルクロリ
ド(37.4g)を注入した。次に、トリエチルアミン(2
5g)を−5℃以下で滴下し、そのまま1時間撹拌した
後、ジメチルアミン塩酸塩(21.3g)を加え、さらにト
リエチルアミン(40g)を−5℃以下で滴下し、その
まま1時間撹拌した。反応液に10%食塩水(125m
l)を加えて分液の後、塩化メチレン層を1N−塩酸水
(250ml)、1N−水酸化ナトリウム水溶液(125
ml)、10%食塩水(125ml×2回)で順次洗浄し、
硫酸マグネシウムで乾燥後、溶媒留去し、(2S,4
R)−N,N−ジメチル−1−アリルオキシカルボニル
−4−メタンスルホニルオキシ−2−ピロリジンカルボ
キシアミド(36g)を含む油状の残渣を42.5g得た。
この残渣をn−ヘキサンと酢酸エチルの混合溶媒で結晶
化して融点(mp)64〜66℃の結晶を得た。Trans-1-allyloxycarbonyl-
Crude crystals (31 g) containing 4-hydroxy-L-proline (28.6 g) were dissolved in methylene chloride (465 ml), triethylamine (6.6 g) was added thereto, and methylene chloride (95 ml) was added under reflux. An azeotropic dehydration was performed by distilling the same amount. After performing azeotropic dehydration three more times by the same operation, the mixture was cooled to -10 ° C, and methanesulfonyl chloride (37.4 g) was injected. Next, triethylamine (2
5 g) was added dropwise at −5 ° C. or lower, and the mixture was stirred for 1 hour. Then, dimethylamine hydrochloride (21.3 g) was added, and triethylamine (40 g) was added dropwise at −5 ° C. or lower, and the mixture was stirred for 1 hour. A 10% saline solution (125 m
l) was added and the mixture was separated. The methylene chloride layer was separated with 1N aqueous hydrochloric acid (250 ml) and 1N aqueous sodium hydroxide (125 ml).
ml), sequentially washed with 10% saline (125 ml × 2 times),
After drying over magnesium sulfate, the solvent was distilled off, and (2S, 4
42.5 g of an oily residue containing (R) -N, N-dimethyl-1-allyloxycarbonyl-4-methanesulfonyloxy-2-pyrrolidinecarboxamide (36 g) was obtained.
The residue was crystallized with a mixed solvent of n-hexane and ethyl acetate to obtain crystals having a melting point (mp) of 64 to 66 ° C.
【0029】 IR(Nujol ):1685, 1645cm-1。IR (Nujol): 1685, 1645 cm -1 .
【0030】 参考例4Reference Example 4
【化13】 Embedded image
【0031】(2S,4S)−N,N−ジメチル−1−
アリルオキシカルボニル−4−ベンゾイルチオ−2−ピ
ロリジンカルボキシアミド(3.62g)をメタノール(5.
2ml )に溶解し、氷冷下に28%ナトリウムメトキシド
−メタノール溶液(2.025 g)を滴下した後、そのまま
30分撹拌した。反応液に塩化メチレン(20ml)、水
(20ml)を加えて分液し、水層を塩化メチレン(20
ml)で洗浄した後、2,6−ジ−t−ブチル−4−メチ
ルフェノール(BHT)(22mg) を加え、2N−塩酸
水(5.5ml )を氷冷下に滴下して酸性とし、塩化メチレ
ン(20ml)、さらに塩化メチレン(10ml)で2回抽
出し、減圧下で溶媒留去して油状の(2S,4S)−
N,N−ジメチル−1−アリルオキシカルボニル−4−
メルカプト−2−ピロリジンカルボキシアミド(2.45
g)を得た。(2S, 4S) -N, N-dimethyl-1-
Allyloxycarbonyl-4-benzoylthio-2-pyrrolidinecarboxamide (3.62 g) was added to methanol (5.
2 ml), and a 28% sodium methoxide-methanol solution (2.025 g) was added dropwise under ice-cooling, followed by stirring for 30 minutes. Methylene chloride (20 ml) and water (20 ml) were added to the reaction solution, and the mixture was separated. The aqueous layer was separated with methylene chloride (20 ml).
Then, 2,6-di-t-butyl-4-methylphenol (BHT) (22 mg) was added, and 2N aqueous hydrochloric acid (5.5 ml) was added dropwise under ice-cooling to acidify the solution. The mixture was extracted twice with methylene (20 ml) and then with methylene chloride (10 ml), and the solvent was distilled off under reduced pressure to give an oily (2S, 4S)
N, N-dimethyl-1-allyloxycarbonyl-4-
Mercapto-2-pyrrolidinecarboxamide (2.45
g) was obtained.
【0032】 IR(neat):1700, 1650cm-1; NMR(CDCl3 ) δ:1.85(1H,m), 1.88(1H,d,J=
8.9Hz), 2.65(1H,m), 2.92(1/3x3H,S), 2.94(2/3x3H,S), 3.00(1
/3x3H,S),3.05(2/3x3H,S), 3.20(1H,m), 3.36(1H,t,J=1
0.0Hz), 4.02(1H,m),4.51〜4.67(3H,m), 5.14〜5.29(2
H,m), 5.84(1H,m)。IR (neat): 1700, 1650 cm -1 ; NMR (CDCl 3 ) δ: 1.85 (1H, m), 1.88 (1H, d, J =
8.9Hz), 2.65 (1H, m), 2.92 (1 / 3x3H, S), 2.94 (2 / 3x3H, S), 3.00 (1
/3x3H,S),3.05(2/3x3H,S), 3.20 (1H, m), 3.36 (1H, t, J = 1
0.0Hz), 4.02 (1H, m), 4.51 to 4.67 (3H, m), 5.14 to 5.29 (2
H, m), 5.84 (1H, m).
フロントページの続き (56)参考文献 特開 昭60−104088(JP,A) 特開 昭60−19787(JP,A) 特開 平3−275685(JP,A) 特開 平5−230061(JP,A) (58)調査した分野(Int.Cl.6,DB名) C07D 207/00 - 207/50 CA(STN) CAOLD(STN) REGISTRY(STN)Continuation of the front page (56) References JP-A-60-10088 (JP, A) JP-A-60-19787 (JP, A) JP-A-3-275685 (JP, A) JP-A-5-230061 (JP) , A) (58) Fields investigated (Int. Cl. 6 , DB name) C07D 207/00-207/50 CA (STN) CAOLD (STN) REGISTRY (STN)
Claims (2)
基を示し、R1 は水素原子、低級アルキル基、低級アル
ケニル基、アラルキル基もしくは置換低級アルキル基を
示し、R2 は低級アルキル基、低級アルケニル基、アラ
ルキル基もしくは置換低級アルキル基を示すか、または
R1 およびR2 は互いに結合し一緒になってアルキレン
鎖、または酸素原子、硫黄原子もしくは低級アルキル置
換の窒素原子を介するアルキレン鎖を表わして隣接する
窒素原子とともに4〜7員環の環状アミノ基を示す。]
で表わされるピロリジン誘導体。1. A compound of the general formula (1) Wherein Ph represents a phenyl group, R represents an amino-protecting group, R 1 represents a hydrogen atom, a lower alkyl group, a lower alkenyl group, an aralkyl group or a substituted lower alkyl group, and R 2 represents a lower alkyl group. Or a lower alkenyl group, an aralkyl group or a substituted lower alkyl group, or R 1 and R 2 are bonded to each other to form an alkylene chain, or an alkylene chain via an oxygen atom, a sulfur atom, or a nitrogen atom substituted with a lower alkyl group. The chain represents a 4- to 7-membered cyclic amino group together with an adjacent nitrogen atom. ]
A pyrrolidine derivative represented by the formula:
一般式(2) 【化2】 [式中、Xは水酸基の活性エステル基を示し、Rはアミ
ノ基の保護基を示し、R1 は水素原子、低級アルキル
基、低級アルケニル基、アラルキル基もしくは置換低級
アルキル基を示し、R2 は低級アルキル基、低級アルケ
ニル基、アラルキル基もしくは置換低級アルキル基を示
すか、またはR1およびR2 は互いに結合し一緒になっ
てアルキレン鎖、または酸素原子、硫黄原子もしくは低
級アルキル置換の窒素原子を介するアルキレン鎖を表わ
して隣接する窒素原子とともに4〜7員環の環状アミノ
基を示す。]で表わされる中間体をチオ安息香酸のアル
カリ金属塩と加熱処理することを特徴とする一般式
(1) 【化3】 [式中、Phはフェニル基を示し、R、R1 およびR2
は前記と同じ意味を有す。]で表わされるピロリジン誘
導体の製造方法。2. General formula (2) derived from 4-hydroxyproline [Wherein, X represents an active ester group of a hydroxyl group, R represents an amino-protecting group, R 1 represents a hydrogen atom, a lower alkyl group, lower alkenyl group, an aralkyl group or a substituted lower alkyl group, R 2 Represents a lower alkyl group, a lower alkenyl group, an aralkyl group or a substituted lower alkyl group, or R 1 and R 2 are bonded to each other to form an alkylene chain, or an oxygen atom, a sulfur atom or a nitrogen atom substituted with a lower alkyl group. Represents a 4- to 7-membered cyclic amino group together with an adjacent nitrogen atom, which represents an alkylene chain via Wherein the intermediate represented by the general formula (1) is heat-treated with an alkali metal salt of thiobenzoic acid. [In the formula, Ph represents a phenyl group, and R, R 1 and R 2
Has the same meaning as described above. ] A method for producing a pyrrolidine derivative represented by the formula:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2411400A JP2955886B2 (en) | 1990-12-18 | 1990-12-18 | Pyrrolidine derivative and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2411400A JP2955886B2 (en) | 1990-12-18 | 1990-12-18 | Pyrrolidine derivative and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04217661A JPH04217661A (en) | 1992-08-07 |
JP2955886B2 true JP2955886B2 (en) | 1999-10-04 |
Family
ID=18520413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2411400A Expired - Fee Related JP2955886B2 (en) | 1990-12-18 | 1990-12-18 | Pyrrolidine derivative and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2955886B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249972A (en) * | 2011-05-27 | 2011-11-23 | 菏泽睿智科技开发有限公司 | Method for synthesizing novel chiral lateral chain of meropenem |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4689803B2 (en) * | 2000-09-11 | 2011-05-25 | 住友化学株式会社 | Process for producing (2S, 4S) -N, N-dimethyl-1-allyloxycarbonyl-4-benzoylthio-2-pyrrolidinecarboxamide |
JP4619505B2 (en) * | 2000-09-21 | 2011-01-26 | 住友化学株式会社 | Process for producing (2S, 4R) -N, N-dimethyl-1-allyloxycarbonyl-4-substituted-2-pyrrolidinecarboxamide |
JP2006001841A (en) * | 2004-06-15 | 2006-01-05 | Sumitomo Chemical Co Ltd | Preparation method of nitrogen-containing heterocyclic compound |
-
1990
- 1990-12-18 JP JP2411400A patent/JP2955886B2/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102249972A (en) * | 2011-05-27 | 2011-11-23 | 菏泽睿智科技开发有限公司 | Method for synthesizing novel chiral lateral chain of meropenem |
Also Published As
Publication number | Publication date |
---|---|
JPH04217661A (en) | 1992-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2564024C2 (en) | Intermediate products for producing neutral endopeptidase inhibitors and method for production thereof | |
RU2201937C2 (en) | D-proline derivatives | |
US5281612A (en) | Naphthyridine antibacterial agents | |
JP2010501589A5 (en) | ||
SU1077565A3 (en) | Process for preparing derivatives of 1-acyl-2-cyanoaziridines or their salts | |
US10358423B2 (en) | Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamdes | |
JP3091297B2 (en) | Pyrrolidine derivative and method for producing the same | |
DE69919663T2 (en) | Processes and hydantoin intermediates for the synthesis of wax hormone secretion promoters | |
JPS59130863A (en) | Manufacture of 4-amino-5-hexanoic acid | |
JP2955886B2 (en) | Pyrrolidine derivative and method for producing the same | |
JP2708117B2 (en) | Method for synthesizing N-acyl auxiliary | |
WO2006095362A1 (en) | Process for preparing levetiracetam | |
WO2004073709A1 (en) | Antimicrobial agents | |
AU761721B2 (en) | Method for producing enantiomer-free N-methyl-N- ((1S)-1-phenyl- 2-((3S)- 3-hydroxypyrrolidine- 1-yl)ethyl)- 2,2-diphenyl acetamide | |
US5668164A (en) | Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds | |
US4891430A (en) | Process for synthesizing active esters of carboxylic acids, new alpha-halogenated carbonates which are useful for this synthesis and the method of producing them | |
NO812871L (en) | PROCEDURE FOR PREPARATION OF N-SUBSTITUTED N-PYRROLIDINES | |
JPS6023363A (en) | N-(substituted methyl)-azetidin-2-ones | |
US5565476A (en) | N-(hydroxyethyl)butanediamide derivatives | |
Yamagata et al. | Synthesis of 1‐acyl‐2‐oxo‐3‐pyrrolidinecarbonitriles by the reaction of 2‐acylamino‐4, 5‐dihydro‐3‐furancarbonitriles with sodium iodide | |
CZ239496A3 (en) | Substituted 4h-pyrans, process of their preparation, their use and pharmaceutical composition containing thereof | |
US11548859B2 (en) | Method for producing (5,S)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4Hisoxazol-3-yl]-2-methyl-benzoic acid | |
WO1994006766A1 (en) | Chiral quinolone intermediates | |
JPH01311060A (en) | 3, 4-dihydroxy-2-pyroliginone derivative | |
US6531594B2 (en) | Process for producing 1H-3-aminopyrrolidine and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080723 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080723 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090723 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090723 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100723 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |